These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 21818765

  • 1. Pyrazinamide-induced sideroblastic anemia.
    Colucci G, Silzle T, Solenthaler M.
    Am J Hematol; 2012 Mar; 87(3):305. PubMed ID: 21818765
    [No Abstract] [Full Text] [Related]

  • 2. Tuberculosis control programme guidelines--treatment regimens.
    Durrheim DN, Belt EL.
    S Afr Med J; 1996 Oct; 86(10):1293-4. PubMed ID: 8955740
    [No Abstract] [Full Text] [Related]

  • 3. [Ascites by peritoneal tuberculosis].
    de Escalante Yangüela B, Aibar Arregui M, Sáenz Abad D, Torrubia Pérez CB.
    An Med Interna; 2007 May; 24(5):253-4. PubMed ID: 17929388
    [No Abstract] [Full Text] [Related]

  • 4. [Cervical spondylodiscitis: one pathogen may hide another].
    Toubiana J, Salomon J, Ader F, Perronne C, Carlier R, Bernard L.
    Med Mal Infect; 2006 Jan; 36(1):55-7. PubMed ID: 16309869
    [Abstract] [Full Text] [Related]

  • 5. [Loculated ascitis by peritoneal tuberculosis].
    de Escalante Yangüela B, Aibar Arregui M, Sáenz Abad D, Blanca Torrubia Pérez C.
    An Med Interna; 2007 Apr; 24(4):205-6. PubMed ID: 17879484
    [No Abstract] [Full Text] [Related]

  • 6. Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
    Rosenthal IM, Zhang M, Almeida D, Grosset JH, Nuermberger EL.
    Am J Respir Crit Care Med; 2008 Nov 01; 178(9):989-93. PubMed ID: 18723432
    [Abstract] [Full Text] [Related]

  • 7. Rifampicin allergy confirmed by an intradermal test, but with a negative patch test.
    Strauss RM, Green ST, Gawkrodger DJ.
    Contact Dermatitis; 2001 Aug 01; 45(2):108. PubMed ID: 11553123
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar 01; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 12. Moxifloxacin-induced arthropathy.
    Wong HY, Chau CH, Yew WW.
    Int J Tuberc Lung Dis; 2007 Jan 01; 11(1):117. PubMed ID: 17217142
    [No Abstract] [Full Text] [Related]

  • 13. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1988 Apr 08; 30(763):43-4. PubMed ID: 3352531
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S, Fischer P, Weinecke W.
    Z Erkr Atmungsorgane; 1989 Apr 08; 173(1):87-96. PubMed ID: 2800620
    [No Abstract] [Full Text] [Related]

  • 17. Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.
    Roberts CH, Smith C, Breen R, Gadhok R, Murphy M, Aryee A, Cropley I, Bhagani S, Hopkins S, Lipman M.
    Int J Tuberc Lung Dis; 2011 Sep 08; 15(9):1275-6. PubMed ID: 21943863
    [No Abstract] [Full Text] [Related]

  • 18. [Cutaneous reaction after pyrazinamide initiation].
    Mulliez P, Mbassi Fouda FL, Roy Saint-Georges F.
    Med Mal Infect; 2011 Sep 08; 41(9):499-500. PubMed ID: 21458177
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Centrofacial granulomatous inflammation].
    Maetzke J, Hinrichs R, Sigge A, Scharffetter-Kochanek K.
    Hautarzt; 2007 Nov 08; 58(11):976-8. PubMed ID: 17476470
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.